HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: results of a multicenter phase II trial.

Abstract
The aim of this study was to assess the accuracy of double-contrast magnetic resonance imaging (MRI) with rectal application of the superparamagnetic iron oxide contrast agent (SPIO) ferristene and IV gadodiamide for preoperative staging of rectal cancer. In a randomized phase II dose-ranging trial, 113 patients were studied preoperatively with one of four different formulations of ferristene (Abdoscan) as an enema before MRI. T1-weighted spin-echo (T1w SE) and T2w turbo spin-echo (TSE) single-contrast images were obtained as well as T1w SE and gradient-echo (GRE) double-contrast images after IV gadodiamide injection (Omniscan). Images were assessed qualitatively, and TNM tumor stage was compared with histopathology. High-viscosity ferristene formulations were superior to low-viscosity formulations in tumor staging (accuracy 90% vs 74%, P < 0.01). There was no significant difference between high and low iron content ferristene. MRI had a sensitivity of 97%, specificity of 50%, and accuracy of 82% for staging of rectal carcinoma higher than T2 stage. At receiver operator characteristic (ROC) analysis, MR differentiation between T1/T2 and T3/T4 tumor stages yielded a ROC index of 0.848. Double-contrast MRI is an accurate method for preoperative staging of rectal cancer.
AuthorsA G Maier, B Kersting-Sommerhoff, J W Reeders, W Judmaier, W Schima, A A Annweiler, M Meusel, N O Wallengren
JournalJournal of magnetic resonance imaging : JMRI (J Magn Reson Imaging) Vol. 12 Issue 5 Pg. 651-60 (Nov 2000) ISSN: 1053-1807 [Print] United States
PMID11050634 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Contrast Media
  • Ferric Compounds
  • ferristene
  • gadodiamide
  • Gadolinium DTPA
Topics
  • Adenocarcinoma (diagnosis, pathology, surgery)
  • Administration, Rectal
  • Adult
  • Aged
  • Biopsy, Needle
  • Chi-Square Distribution
  • Contrast Media
  • Dose-Response Relationship, Drug
  • Female
  • Ferric Compounds
  • Gadolinium DTPA
  • Humans
  • Image Processing, Computer-Assisted
  • Injections, Intravenous
  • Magnetic Resonance Imaging (methods)
  • Male
  • Middle Aged
  • Neoplasm Staging (methods)
  • Preoperative Care
  • Probability
  • ROC Curve
  • Rectal Neoplasms (diagnosis, pathology, surgery)
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: